Leukemia, Biphenotypic, Acute - 18 Studies Found Recruiting : Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD : Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Acut : 2014-08-18 : Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Active, not recruiting : Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children : Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Acut : 2013-05-15 : Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Completed : Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies : Hodgkin Lymphoma Lymphocytic Leukemia Chronic Myelogenous Leukemia Acute Lymphoblastic Leukemia : 2013-09-24 : Drug: tacrolimus Tacrolimus 0. Recruiting : HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide : Myelodysplastic Syndrome (MDS) Chronic Lymphocytic Leukemia (CLL) Drug: Fludarabine Completed : Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation : Leukemia Lymphoma Allogeneic Haematopoietic Stem Cell Tran : 2009-10-02 : Drug: Busulfan Test Dose 32 mg Not yet recruiting : Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies : Hematologic Malignancy : 2016-03-16 : Drug: Fludarabine Recruiting : Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML) : Leukemia : 2014-04-14 : Drug: Cladribine <<< Previous